WallStreetZenWallStreetZen

NYSE: DOC
Healthpeak Properties Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DOC

Based on 9 analysts offering 12 month price targets for Healthpeak Properties Inc

Min Forecast
$17.00+1.31%
Avg Forecast
$18.89+12.57%
Max Forecast
$21.00+25.15%

Should I buy or sell DOC stock?

Based on 9 analysts offering ratings for Healthpeak Properties Inc.

Buy
Strong Buy
1 analysts 11.11%
Buy
3 analysts 33.33%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DOC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates DOC as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their DOC stock forecasts and price targets.

DOC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-04
lockedlocked$00.00+00.00%2026-02-02
lockedlocked$00.00+00.00%2026-01-09
lockedlocked$00.00+00.00%2025-12-16
lockedlocked$00.00+00.00%2025-11-12
Cantor Fitzgerald
Top 24%
77
HoldInitiates Coverage On$20.00+19.19%2025-10-01
Raymond James
Top 21%
80
BuyUpgrades$20.00+19.19%2025-09-15
Morgan Stanley
Bottom 4%
4
Strong BuyMaintains$21.00+25.15%2025-08-22
Deutsche Bank
Top 20%
81
HoldDowngrades$18.00+7.27%2025-08-20

1 of 1

Forecast return on equity

Is DOC forecast to generate an efficient return?

Company
3.09%
Industry
6.34%
Market
216.29%
DOC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DOC forecast to generate an efficient return on assets?

Company
1.14%
Industry
3.84%
DOC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DOC earnings per share forecast

What is DOC's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.26+164%
Avg 2 year Forecast
$0.29+190.9%
Avg 3 year Forecast
$0.36+258.6%
DOC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

DOC revenue forecast

What is DOC's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$2.8B-0.05%
Avg 2 year Forecast
$2.9B+2.14%
Avg 3 year Forecast
$3.0B+6.61%
DOC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DOC earnings growth forecast

How is DOC forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
51.13%
Industry
31.66%
Market
39.92%
DOC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
DOC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
DOC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

DOC revenue growth forecast

How is DOC forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
1.82%
Industry
12.55%
Market
22.81%
DOC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DOC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DOC vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
DOC$16.78$18.89+12.57%Buy
OHI$42.96$46.22+7.59%Buy
AHR$46.82$54.89+17.23%Strong Buy
CTRE$36.56$40.89+11.84%Strong Buy
HR$16.56$20.00+20.77%Buy
View Top Healthcare Facility REIT Stocks

Healthpeak Properties Stock Forecast FAQ

Is Healthpeak Properties Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: DOC) stock is to Buy DOC stock.

Out of 9 analysts, 1 (11.11%) are recommending DOC as a Strong Buy, 3 (33.33%) are recommending DOC as a Buy, 5 (55.56%) are recommending DOC as a Hold, 0 (0%) are recommending DOC as a Sell, and 0 (0%) are recommending DOC as a Strong Sell.

If you're new to stock investing, here's how to buy Healthpeak Properties stock.

What is DOC's earnings growth forecast for 2026-2028?

(NYSE: DOC) Healthpeak Properties's forecast annual earnings growth rate of 51.13% is forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 31.66%, and it is also forecast to beat the US market's average forecast earnings growth rate of 39.92%.

Healthpeak Properties's earnings in 2026 is $70,513,000.On average, 9 Wall Street analysts forecast DOC's earnings for 2026 to be $183,491,615, with the lowest DOC earnings forecast at $108,982,899, and the highest DOC earnings forecast at $240,832,745. On average, 7 Wall Street analysts forecast DOC's earnings for 2027 to be $202,188,299, with the lowest DOC earnings forecast at $129,417,192, and the highest DOC earnings forecast at $291,918,479.

In 2028, DOC is forecast to generate $249,242,777 in earnings, with the lowest earnings forecast at $190,720,073 and the highest earnings forecast at $313,812,365.

What is DOC's revenue growth forecast for 2026-2028?

(NYSE: DOC) Healthpeak Properties's forecast annual revenue growth rate of 1.82% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 12.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.81%.

Healthpeak Properties's revenue in 2026 is $2,822,512,000.On average, 16 Wall Street analysts forecast DOC's revenue for 2026 to be $1,960,719,115,537, with the lowest DOC revenue forecast at $1,875,228,703,906, and the highest DOC revenue forecast at $2,062,195,539,099. On average, 12 Wall Street analysts forecast DOC's revenue for 2027 to be $2,003,811,843,351, with the lowest DOC revenue forecast at $1,871,058,439,924, and the highest DOC revenue forecast at $2,153,941,346,703.

In 2028, DOC is forecast to generate $2,091,387,386,973 in revenue, with the lowest revenue forecast at $2,020,492,899,279 and the highest revenue forecast at $2,183,828,238,574.

What is DOC's forecast return on assets (ROA) for 2026-2029?

(NYSE: DOC) forecast ROA is 1.14%, which is lower than the forecast US REIT - Healthcare Facilities industry average of 3.84%.

What is DOC's Price Target?

According to 9 Wall Street analysts that have issued a 1 year DOC price target, the average DOC price target is $18.89, with the highest DOC stock price forecast at $21.00 and the lowest DOC stock price forecast at $17.00.

On average, Wall Street analysts predict that Healthpeak Properties's share price could reach $18.89 by Feb 4, 2027. The average Healthpeak Properties stock price prediction forecasts a potential upside of 12.57% from the current DOC share price of $16.78.

What is DOC's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: DOC) Healthpeak Properties's current Earnings Per Share (EPS) is $0.10. On average, analysts forecast that DOC's EPS will be $0.26 for 2026, with the lowest EPS forecast at $0.16, and the highest EPS forecast at $0.35. On average, analysts forecast that DOC's EPS will be $0.29 for 2027, with the lowest EPS forecast at $0.19, and the highest EPS forecast at $0.42. In 2028, DOC's EPS is forecast to hit $0.36 (min: $0.27, max: $0.45).

What is DOC's forecast return on equity (ROE) for 2026-2029?

(NYSE: DOC) forecast ROE is 3.09%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.